Zimmer Biomet Holdings (ZBH) Tops Q4 EPS by 5c; offers guidance

Go back to Zimmer Biomet Holdings (ZBH) Tops Q4 EPS by 5c; offers guidance

Citi Opens 30-Day Positive Catalyst Watch on Zimmer Biomet (ZBH)

February 9, 2024 6:20 AM EST

Citi analyst Joanna Wuensch reiterated a Neutral rating and $130.00 price target on Zimmer Biomet (NYSE: ZBH)

The analyst comments "ZBH has moved out of the corporate restructuring depths and into the accelerating growth phase (what many call the show me... More